Dr. Martens (LON:DOCS) Stock Price Down 12.4% – Here’s What Happened

Shares of Dr. Martens plc (LON:DOCS) traded down 12.4% on Tuesday . The stock traded as low as GBX 65.70 and last traded at GBX 66.28. 2,536,393 shares changed hands during mid-day trading, an increase of 51% from the average session volume of 1,682,759 shares. The stock had previously closed at GBX 75.65.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Peel Hunt reaffirmed a “buy” rating on shares of Dr. Martens in a research report on Thursday, November 20th. Berenberg Bank restated a “buy” rating on shares of Dr. Martens in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of GBX 6,000.

Dr. Martens Stock Up 4.0%

The firm has a market capitalization of £660.64 million, a price-to-earnings ratio of 40.21, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The business’s 50 day moving average is GBX 75.88 and its 200-day moving average is GBX 83.26.

Dr. Martens (LON:DOCS) last issued its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Equities analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Activity

In related news, insider Robert Hanson bought 96,000 shares of the company’s stock in a transaction on Friday, December 5th. The stock was bought at an average cost of GBX 79 per share, with a total value of £75,840. Insiders bought 97,130 shares of company stock valued at $7,673,816 over the last three months. Insiders own 2.79% of the company’s stock.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.